Functional brown adipose tissue imaging technique
US9283317B2 · kind B2 · utility
2Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2013 |
| Grant date | Mar 15, 2016 |
| Priority date | — |
| Expiry date | Nov 9, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01R33/5601
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Disclosed embodiments for assessing brown adipose tissue use imaging of metabolic contrast agents. For example, activated brown adipose tissue may be assessed by evaluating a difference in production of the hyperpolarized 13C metabolic contrast agent from a pre-polarized 13C metabolic contrast agent precursor before and after exposure of the subject to an activating event or agent. In one embodiment, the subject is given a dose of norepinephrine, and the production of the hyperpolarized 13C metabolic contrast agent before and after the dose is assessed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.